4//SEC Filing
Leonard Frank X 4
Accession 0001562180-24-006039
CIK 0001645113other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:17 PM ET
Size
5.5 KB
Accession
0001562180-24-006039
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leonard Frank X
EVP, Pres., Novocure Oncology
Transactions
- Award
Ordinary Shares
2024-06-28$12.24/sh+1,736$21,249→ 161,834 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2024 through June 30, 2024. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2024.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001822879
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 4:17 PM ET
- Size
- 5.5 KB